Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.

Saved in:
Bibliographic Details
Title: Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.
Authors: Van de Walle I; argenx, Ghent, Belgium. IVandeWalle@argenx.com., Bracke L; argenx, Ghent, Belgium., Olesen HG; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark., van Bragt T; Curare Consulting BV, Liempde, The Netherlands., Cadour S; argenx, Ghent, Belgium., De Decker P; argenx, Ghent, Belgium., Ciurlia G; argenx, Ghent, Belgium., Pannecoucke E; argenx, Ghent, Belgium., Persson EK; argenx, Ghent, Belgium., Van de Steen O; argenx, Ghent, Belgium., Leng X; argenx, Ghent, Belgium., Andersen GR; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark., Gandini D; argenx, Ghent, Belgium., Hack CE; argenx, Ghent, Belgium.
Source: Nature communications [Nat Commun] 2025 Aug 16; Vol. 16 (1), pp. 7639. Date of Electronic Publication: 2025 Aug 16.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40819168
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Van+de+Walle+I%22">Van de Walle I</searchLink>; argenx, Ghent, Belgium. IVandeWalle@argenx.com.<br /><searchLink fieldCode="AU" term="%22Bracke+L%22">Bracke L</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Olesen+HG%22">Olesen HG</searchLink>; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark.<br /><searchLink fieldCode="AU" term="%22van+Bragt+T%22">van Bragt T</searchLink>; Curare Consulting BV, Liempde, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cadour+S%22">Cadour S</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Decker+P%22">De Decker P</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Ciurlia+G%22">Ciurlia G</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Pannecoucke+E%22">Pannecoucke E</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Persson+EK%22">Persson EK</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+de+Steen+O%22">Van de Steen O</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Leng+X%22">Leng X</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Andersen+GR%22">Andersen GR</searchLink>; Department of Molecular Biology and Genetics - Protein Science, Universitetsbyen 81, 8000, Aarhus C, Denmark.<br /><searchLink fieldCode="AU" term="%22Gandini+D%22">Gandini D</searchLink>; argenx, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Hack+CE%22">Hack CE</searchLink>; argenx, Ghent, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Aug 16; Vol. 16 (1), pp. 7639. <i>Date of Electronic Publication: </i>2025 Aug 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40819168
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-62925-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7639
    Titles:
      – TitleFull: Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Van de Walle I
      – PersonEntity:
          Name:
            NameFull: Bracke L
      – PersonEntity:
          Name:
            NameFull: Olesen HG
      – PersonEntity:
          Name:
            NameFull: van Bragt T
      – PersonEntity:
          Name:
            NameFull: Cadour S
      – PersonEntity:
          Name:
            NameFull: De Decker P
      – PersonEntity:
          Name:
            NameFull: Ciurlia G
      – PersonEntity:
          Name:
            NameFull: Pannecoucke E
      – PersonEntity:
          Name:
            NameFull: Persson EK
      – PersonEntity:
          Name:
            NameFull: Van de Steen O
      – PersonEntity:
          Name:
            NameFull: Leng X
      – PersonEntity:
          Name:
            NameFull: Andersen GR
      – PersonEntity:
          Name:
            NameFull: Gandini D
      – PersonEntity:
          Name:
            NameFull: Hack CE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 08
              Text: 2025 Aug 16
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1